본문 바로가기
KERD
논문KCI 등재

Which Severe Mental Illnesses Most Increase the Risk of Developing Dementia? Comparing the Risk of Dementia in Patients with Schizophrenia, Major Depressive Disorder and Bipolar Disorder

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Objective: Previous studies have shown that certain severe mental illnesses (SMIs) increase the risk of dementia, but those that increase the risk to a greater degree in comparison with other SMIs are unknown. Furthermore, physical illnesses may alter the risk of developing dementia, but these cannot be well-controlled. Methods: Using the Taiwan National Health Insurance Research Database, patients with schizophrenia, bipolar disorder and major depressive disorder (MDD) were recruited. We also recruited normal healthy subjects as the control group. All subjects were aged over 60 years, and the duration of follow-up was from 2008 to 2015. Multiple confounders were adjusted, including physical illnesses and other variables. Use of medications, especially benzodiazepines, was analyzed in a sensitivity analysis. Results: 36,029 subjects (MDD: 23,371, bipolar disorder: 4,883, schizophrenia: 7,775) and 108,084 control subjects were recruited after matching according to age and sex. The results showed that bipolar disorder had the highest hazard ratio (HR) (HR: 2.14, 95% confidence interval [CI]: 1.99−2.30), followed by schizophrenia (HR: 2.06, 95% CI: 1.93−2.19) and MDD (HR: 1.60, 95% CI: 1.51−1.69). The results remained robust after adjusting for covariates, and sensitivity analysis showed similar results. Anxiolytics use did not increase the risk of dementia in any of the three groups of SMI patients. Conclusion: SMIs increase the risk of dementia, and among them, bipolar disorder confers the greatest risk of developing dementia. Anxiolytics may not increase the risk of developing dementia in patients with an SMI, but still need to be used with caution in clinical practices.

Abstract

Objective: Previous studies have shown that certain severe mental illnesses (SMIs) increase the risk of dementia, but those that increase the risk to a greater degree in comparison with other SMIs are unknown. Furthermore, physical illnesses may alter the risk of developing dementia, but these cannot be well-controlled. Methods: Using the Taiwan National Health Insurance Research Database, patients with schizophrenia, bipolar disorder and major depressive disorder (MDD) were recruited. We also recruited normal healthy subjects as the control group. All subjects were aged over 60 years, and the duration of follow-up was from 2008 to 2015. Multiple confounders were adjusted, including physical illnesses and other variables. Use of medications, especially benzodiazepines, was analyzed in a sensitivity analysis. Results: 36,029 subjects (MDD: 23,371, bipolar disorder: 4,883, schizophrenia: 7,775) and 108,084 control subjects were recruited after matching according to age and sex. The results showed that bipolar disorder had the highest hazard ratio (HR) (HR: 2.14, 95% confidence interval [CI]: 1.99−2.30), followed by schizophrenia (HR: 2.06, 95% CI: 1.93−2.19) and MDD (HR: 1.60, 95% CI: 1.51−1.69). The results remained robust after adjusting for covariates, and sensitivity analysis showed similar results. Anxiolytics use did not increase the risk of dementia in any of the three groups of SMI patients. Conclusion: SMIs increase the risk of dementia, and among them, bipolar disorder confers the greatest risk of developing dementia. Anxiolytics may not increase the risk of developing dementia in patients with an SMI, but still need to be used with caution in clinical practices.

참고문헌 (42)

  1. Conio B, "Opposite effects of dopamine and serotonin on resting-state networks : Review and implications for psychiatric disorders", Mol Psychiatry, 25, pp.82~93 (2020)
  2. Krystal JH, "Neuroplasticity as a target for the pharmacotherapy of psychiatric disorders : New opportunities for synergy with psychotherapy", Biol Psychiatry, 62, pp.833~834 (2007)
  3. Wang AK, "Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients : Comparisons between schizophrenia, bipolar disorder, and depression", Schizophr Bull, 44, pp.75~83 (2018)
  4. Bradshaw NJ, "Protein misassembly and aggregation as potential convergence points for non-genetic causes of chronic mental illness", Mol Psychiatry, 24, pp.936~951 (2019)
  5. Gold S, "Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia", Am J Psychiatry, 156, pp.1342~1348 (1999)
  6. Baune BT, "Impact of psychiatric and medical comorbidity on cognitive function in depression", Psychiatry Clin Neurosci, 63, pp.392~400 (2009)
  7. Baune BT, "A review on the impact of cognitive dysfunction on social, occupational, and general functional outcomes in bipolar disorder", Bipolar Disord, 17(Suppl 2), pp.41~55 (2015)
  8. Diniz BS, "History of bipolar disorder and the risk of dementia : A systematic review and meta-analysis", Am J Geriatr Psychiatry, 25, pp.357~362 (2017)
  9. Blazer D, "Bipolar disorder and dementia : Weighing the evidence", Am J Geriatr Psychiatry, 25, pp.363~364 (2017)
  10. Lyketsos CG, "Dementia in patients with schizophrenia : Evidence for heterogeneity", JAMA Psychiatry, 72, pp.1075~1076 (2015)
  11. Asmer MS, "Meta-analysis of the prevalence of major depressive disorder among older adults with dementia", J Clin Psychiatry, 79, pp.17~ (2018)
  12. Bhattarai JJ, "Dementia and cognitive impairment among U. S. veterans with a history of MDD or PTSD : A retrospective cohort study based on sex and race", J Aging Health, 31, pp.1398~1422 (2019)
  13. Ribe AR, "Long-term risk of dementia in persons with schizophrenia : A Danish population-based cohort study", JAMA Psychiatry, 72, pp.1095~1101 (2015)
  14. Chang WH, "Bridging the associations between dopamine, brain volumetric variation and IQ in drug-naïve schizophrenia", Schizophr Res, 220, pp.248~253 (2020)
  15. Martínez-Arán A, "Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder", Am J Psychiatry, 161, pp.262~270 (2004)
  16. Byers AL, "Depression and risk of developing dementia", Nat Rev Neurol, 7, pp.323~331 (2011)
  17. Brzezińska A, "Depression in dementia or dementia in depression? Systematic review of studies and hypotheses", Curr Alzheimer Res, 17, pp.16~28 (2020)
  18. Lamar M, "Common brain structural alterations associated with cardiovascular disease risk factors and Alzheimer’s dementia : Future directions and implications", Neuropsychol Rev, 30, pp.546~557 (2020)
  19. Ng TP, "Metabolic syndrome and the risk of mild cognitive impairment and progression to dementia : Follow-up of the Singapore longitudinal ageing study cohort", JAMA Neurol, 73, pp.456~463 (2016)
  20. Qian He, "Risk of Dementia in Long-Term Benzodiazepine Users: Evidence from a Meta-Analysis of Observational Studies", Journal of Clinical Neurology, 15(1), pp.9~19 (2019), 대한신경과학회[DOI]
  21. Osler M, "Associations of benzodiazepines, Z-drugs, and other anxiolytics with subsequent dementia in patients with affective disorders : A nationwide cohort and nested case-control study", Am J Psychiatry, 177, pp.497~505 (2020)
  22. Hsieh CY, "Taiwan’s National Health Insurance Research Database : Past and future", Clin Epidemiol, 11, pp.349~358 (2019)
  23. Fine JP, "A proportional hazards model for the subdistribution of a competing risk", J Am Stat Assoc, 94, pp.496~509 (1999)
  24. Tseng LY, "Benzodiazepines, z-hypnotics, and risk of dementia : Special considerations of half-lives and concomitant use", Neurotherapeutics, 17, pp.156~164 (2020)
  25. Liu L, "Is the longterm use of benzodiazepines associated with worse cognition performance in highly educated older adults?", Front Psychiatry, 11, pp.595623~ (2020)
  26. MacQueen GM, "Cognitive dysfunction in major depression and bipolar disorder : Assessment and treatment options", Psychiatry Clin Neurosci, 71, pp.18~27 (2017)
  27. Vöhringer PA, "Cognitive impairment in bipolar disorder and schizophrenia : A systematic review", Front Psychiatry, 4, pp.87~ (2013)
  28. Arnone D, "Magnetic resonance imaging studies in bipolar disorder and schizophrenia : Meta-analysis", Br J Psychiatry, 195, pp.194~201 (2009)
  29. Egger K, "Pattern of brain atrophy in elderly patients with depression revealed by voxel-based morphometry", Psychiatry Res, 164, pp.237~244 (2008)
  30. Jiyoun Lee, "Education as a Protective Factor Moderating the Effect of Depression on Memory Impairment in Elderly Women", PSYCHIATRY INVESTIGATION, 15(1), pp.70~77 (2018), 대한신경정신의학회[DOI]
  31. Pantelis C, "Cognitive intervention in early psychosis-preserving abilities versus remediating deficits", Curr Opin Behav Sci, 4, pp.63~72 (2015)
  32. Brainstorm Consortium, "Analysis of shared heritability in common disorders of the brain", Science, 360, pp.eaap8757~ (2018)
  33. Jónsdóttir H, "Predictors of medication adherence in patients with schizophrenia and bipolar disorder", Acta Psychiatr Scand, 127, pp.23~33 (2013)
  34. Cramer JA, "Compliance with medication regimens for mental and physical disorders", Psychiatr Serv, 49, pp.196~201 (1998)
  35. Ashok AH, "The dopamine hypothesis of bipolar affective disorder : The state of the art and implications for treatment", Mol Psychiatry, 22, pp.666~679 (2017)
  36. Chen G, "Presynaptic glutamatergic dysfunction in bipolar disorder", Biol Psychiatry, 67, pp.1007~1009 (2010)
  37. Chen MH, "Risk of subsequent dementia among patients with bipolar disorder or major depression : A nationwide longitudinal study in Taiwan", J Am Med Dir Assoc, 16, pp.504~508 (2015)
  38. Terao T, "A specific group of patients with diagnostic conversion from depression to bipolar disorder and finally to dementia as a mental GSK-3 disease : A hypothesis", Bipolar Disord, 22, pp.356~359 (2020)
  39. Airagnes G, "Benzodiazepine misuse in the elderly : Risk factors, consequences, and management", Curr Psychiatry Rep, 18, pp.89~ (2016)
  40. Chang WH, "Coexisting geriatric anxiety and depressive disorders may increase the risk of ischemic heart disease mortality-a nationwide longitudinal cohort study", Int J Geriatr Psychiatry, 32, pp.e25~e33 (2017)
  41. de Roos A, "Magnetic resonance imaging of cardiovascular function and the brain : Is dementia a cardiovascular-driven disease?", Circulation, 135, pp.2178~2195 (2017)
  42. Ho SW, "Association of proton pump inhibitors usage with risk of pneumonia in dementia patients", J Am Geriatr Soc, 65, pp.1441~1447 (2017)

관련 논문AI추천

후기 발병 우울증과 알츠하이머형 치매 발생과의 관련성김보라, 김영기, 박상진, 이병욱대한노인정신의학회 · 노인정신의학2011 · 제15권 제1호The Relationship between Cognitive Decline and Psychopathology in Patients with Schizophrenia and Bipolar Disorder김문두, 문지현, 박원명, 박준혁, 서혜진, 윤보현, 이창인, 정영은, 홍성철, Hyunju Yun대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2015 · 제13권 제1호Risk of Dementia in Long-Term Benzodiazepine Users: Evidence from a Meta-Analysis of Observational StudiesLiyuan Li, Qian He, Tang Wu, Xiaofan Fei, Xiaohua Chen대한신경과학회 · Journal of Clinical Neurology2019 · 제15권 제1호Characteristics of Comorbid Physical Disease in Patients With Severe Mental Illness in South Korea: A Nationwide Population-Based Study (2014-2019)Eun Jin Na, Haewoo Lee, Hyun-Bo Sim, Jee Hoon Sohn, Jungsun Lee, Mi Yang, Yoomi Park대한신경정신의학회 · PSYCHIATRY INVESTIGATION2024 · 제21권 제4호Anhedonia and Dysphoria Are Differentially Associated with the Risk of Dementia in the Cognitively Normal Elderly Individuals: A Prospective Cohort Study김신겸, 김정란, 김태희, Bong Jo Kim, Dong Woo Lee, Dong Young Lee, Jin Hyeong Jhoo, Ji Won Han, Jong Chul Youn, Joon Hyuk Park, Jung Jae Lee, Ju Ri Lee, Ki Woong Kim, Kyoung Hwan Lee, Kyung Phil Kwak, Seok Bum Lee, Seok Woo Moon, Seonjeong Byun, Seung-Ho Ryu, Seung Wan Suh, Soon Jai Kwon대한신경정신의학회 · PSYCHIATRY INVESTIGATION2019 · 제16권 제8호Nature and Extent of Physical Comorbidities Among Korean Patients With Mental Illnesses: Pairwise and Network Analysis Based on Health Insurance Claims Data정성훈, Kim Ho Joon, Shin Sam Yi대한신경정신의학회 · PSYCHIATRY INVESTIGATION2022 · 제19권 제6호

이 간행물의 다른 논문 (19건)